Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9966719 | 0.67 | — | — | |
| SCHEMBL13105905 | 0.57 | MAPT (0.30) | HSD17B10 | |
| SCHEMBL12220287 | 0.55 | GPR35 (0.31) | HSD17B10 | |
| SCHEMBL11339677 | 0.55 | POLB (0.33) | — | |
| SCHEMBL2376412 | 0.52 | — | — | |
| SCHEMBL3468019 | 0.52 | HSD17B10 (0.50) | CYP1A2CYP3A4CYP2C19HSD17B10 | |
| SCHEMBL10408804 | 0.50 | KDM4E (0.31) | CYP3A4 | |
| SCHEMBL10401255 | 0.50 | — | — | |
| SCHEMBL9185875 | 0.50 | — | — | |
| SCHEMBL29785816 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11681176-B2 | Solar reflective and absorptive electrically-switchable film and glazing | GAUZY LTD. (IL) | 2023-06-20 | — | — | US | disclosed |
| US-8530673-B2 | Tetrathiafulvalene derivative, and organic film and organic transistor using the same | RICOH COMPANY, LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| EP-2411378-B1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH CO LTD (JP) | 2012-12-19 | — | — | EP | disclosed |
| EP-2411378-B1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH CO LTD (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120035364-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035364-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035364-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2411378-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | Ricoh Company, Ltd. (JP) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010110351-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010110351-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | RICOH COMPANY, LTD. (JP) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035364-A1 | TETRATHIAFULVALENE DERIVATIVE, AND ORGANIC FILM AND ORGANIC TRANSISTOR USING THE SAME | TCOF1, F12, F5 | CYP1A2 467/4885CYP3A4 179/4885CYP2C19 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.